Anika Therapeutics, Inc. (ANIK) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Anika Therapeutics, Inc. (ANIK) - Medical Equipment - Deals and Alliances Profile

Anika Therapeutics, Inc. (ANIK) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Anika Therapeutics, Inc. (ANIK) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
35 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Anika Therapeutics, Inc. (Anika) is a medical technology company which develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regenerative orthopedics products, advanced wound care devices, anti-adhesion gels, viscoelastic ophthalmic products, dental bone grafting adjuncts and joint dysfunction management fluids for horses. Its products are made from hyaluronic acid (HA) based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA.

Anika Therapeutics, Inc. (ANIK) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- De

  
Source:
Document ID
GDME791D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Anika Therapeutics, Inc., Medical Equipment, Deals By Year, 2010 to YTD 201652
Anika Therapeutics, Inc., Medical Equipment Deals By Type, 2010 to YTD 201671
Anika Therapeutics, Inc., Medical Equipment, Deals By Region, 2010 to YTD 201681
Anika Therapeutics, Inc., Medical Equipment, Deals By Market, 2010 to YTD 201691
Anika Therapeutics, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016101
Anika Therapeutics, Inc., Medical Equipment, Deal Details113
  Partnerships111
    Anika Therapeutics Enters Into Licensing Agreement With DePuy Mitek111
    Anika Therapeutics Enters into Co-Marketing into Agreement with Medline for Hyalomatrix121
    Misonix Enters Into Distribution Agreement With Anika Therapeutics131
Anika Therapeutics, Inc. - Key Competitors141
Key Employees151
Locations And Subsidiaries161
  Head Office161
  Other Locations &Subsidiaries161
Recent Developments171
Financial Announcements171
Jul 27, 2016: Anika Reports Second Quarter 2016 Financial Results171
Apr 27, 2016: Anika Reports First Quarter 2016 Financial Results181
Feb 24, 2016: Anika Therapeutics Delivers Strong Performance with Record Product Revenue for the Fourth Quarter and Full Year 2015191
Oct 28, 2015: Anika Therapeutics Reports Robust Financial Performance and Continued Progress on Key Fronts in Third Quarter of 2015201
Jul 29, 2015: Anika Therapeutics Delivers Solid Second Quarter 2015 Financial Results and Continued Pipeline Progress211
Apr 28, 2015: Anika Therapeutics Reports First-Quarter 2015 Financial Results222
Feb 25, 2015: Anika Therapeutics Reports Fourth-Quarter and Full-Year 2014 Financial Results242
Corporate Communications261
Apr 04, 2016: Anika Appoints New Chief Medical Officer and Chief Operations Officer261
Oct 29, 2015: Anika Appoints Richard Hague to Role of Chief Commercial Officer271
Feb 19, 2015: Anika Therapeutics Appoints Dr. Glenn Larsen to its Board of Directors281
Product News291
Apr 28, 2015: Anika Therapeutics Announces Presentation of Seven Abstracts at 12th Annual World Congress of the International Cartilage Repair Society291
Apr 17, 2015: Anika Therapeutics Reports on Cingal 13-01 Study Clinical Trial Top Line Data and Announces the Completion of Cingal 13-02 Study s Patient Enrollment301
Apr 10, 2015: Hyalomatrix Receives CMS Reimbursement Coverage in 11 States311
Apr 08, 2015: Anika Therapeutics Files IDE Application with U.S. FDA for Hyalofast321
Feb 11, 2015: Anika Therapeutics Announces Regulatory Submissions with U.S. FDA and European Regulatory Authorities for Cingal331
Clinical Trials341
Apr 17, 2015: Anika Therapeutics Reports on Cingal 13-01 Study Clinical Trial Top Line Data and Announces the Completion of Cingal 13-02 Study s Patient Enrollment341
Appendix351
  Methodology351
  About GlobalData351
  Contact Us351
  Disclaimer351

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Anika Therapeutics, Inc. (ANIK) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. May 04, 2025. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Anika-Therapeutics-Inc-ANIK-Medical-Equipment-Deals-and-Alliances-Profile-2148-5606>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Anika Therapeutics, Inc. (ANIK) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Anika-Therapeutics-Inc-ANIK-Medical-Equipment-Deals-and-Alliances-Profile-2148-5606>
  
US$ 250.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research